BR0211439A - Composição de carga sinergìstica e comprimido farmacêutico - Google Patents

Composição de carga sinergìstica e comprimido farmacêutico

Info

Publication number
BR0211439A
BR0211439A BR0211439-9A BR0211439A BR0211439A BR 0211439 A BR0211439 A BR 0211439A BR 0211439 A BR0211439 A BR 0211439A BR 0211439 A BR0211439 A BR 0211439A
Authority
BR
Brazil
Prior art keywords
filler composition
synergistically
tablet
pharmaceutical tablet
low
Prior art date
Application number
BR0211439-9A
Other languages
English (en)
Other versions
BRPI0211439B8 (pt
BRPI0211439B1 (pt
Inventor
Antonio Moroni
Nadhamuni G Nerella
Gregory Du Browny
Original Assignee
Isp Investments Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isp Investments Inc filed Critical Isp Investments Inc
Publication of BR0211439A publication Critical patent/BR0211439A/pt
Publication of BRPI0211439B1 publication Critical patent/BRPI0211439B1/pt
Publication of BRPI0211439B8 publication Critical patent/BRPI0211439B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

"COMPOSIçãO DE CARGA SINERGìSTICA E COMPRIMIDO FARMACêUTICO". Composição de carga sinergística para fabricação de comprimidos farmacêuticos de rigidez de comprimido suficiente em força de compressão e friabilidade baixas, para impedir danos ao comprimido, quando do processamento ulterior e sem necessitar de aumento substancial do tamanho do comprimido, compreendendo (a) um copolímero de PVP-VA e (b) uma celulose microcristalina.
BRPI0211439-9A 2001-07-25 2002-05-10 Composition of synergistic charge and pharmaceutical tablet BRPI0211439B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/915.057 2001-07-25
US09/915,057 US6524617B1 (en) 2001-07-25 2001-07-25 Synergistic filler composition
PCT/US2002/014586 WO2003011253A1 (en) 2001-07-25 2002-05-10 Synergistic filler composition

Publications (3)

Publication Number Publication Date
BR0211439A true BR0211439A (pt) 2004-07-20
BRPI0211439B1 BRPI0211439B1 (pt) 2017-09-19
BRPI0211439B8 BRPI0211439B8 (pt) 2021-05-25

Family

ID=25435143

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0211439-9A BRPI0211439B1 (pt) 2001-07-25 2002-05-10 Composition of synergistic charge and pharmaceutical tablet

Country Status (12)

Country Link
US (1) US6524617B1 (pt)
EP (1) EP1416918B1 (pt)
JP (1) JP4805537B2 (pt)
CN (1) CN1268320C (pt)
AT (1) ATE327738T1 (pt)
BR (1) BRPI0211439B1 (pt)
CA (1) CA2454449C (pt)
DE (1) DE60211916T2 (pt)
ES (1) ES2266502T3 (pt)
MX (1) MXPA04000666A (pt)
RU (1) RU2304981C2 (pt)
WO (1) WO2003011253A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6620900B2 (en) * 2002-02-07 2003-09-16 Isp Investments Inc. Proliferous copolymer of vinyl pyrrolidone and vinyl acetate
ES2365012T3 (es) * 2002-11-12 2011-09-20 Elan Pharma International Limited Formas farmacéuticas sólidas de desintegración rápida que no son friables y que comprenden pululano.
US7704528B2 (en) * 2003-05-05 2010-04-27 Isp Investments Inc. Binder composition and method for processing poorly compressible drugs into tablets of predetermined hardness and friability
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
US8168219B2 (en) * 2005-11-30 2012-05-01 Isp Investments Inc. Synergistic binder composition, method for making same, and tablets of an active and said binder having advantageous hardness and friability
CN105188760A (zh) * 2013-03-12 2015-12-23 赫尔克里士公司 共处理的涂覆有硅石的聚合物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU183408B (en) * 1981-04-28 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing oral ratard pharmaceutical compositions
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
DE69617245T2 (de) * 1995-08-17 2002-07-25 Csir Pretoria Produkte mit gesteuerter freisetzung
AT413647B (de) * 1998-11-26 2006-04-15 Sandoz Ag Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten

Also Published As

Publication number Publication date
ES2266502T3 (es) 2007-03-01
WO2003011253A1 (en) 2003-02-13
US6524617B1 (en) 2003-02-25
BRPI0211439B8 (pt) 2021-05-25
CN1268320C (zh) 2006-08-09
BRPI0211439B1 (pt) 2017-09-19
JP4805537B2 (ja) 2011-11-02
EP1416918A4 (en) 2004-08-18
CA2454449A1 (en) 2003-02-13
RU2304981C2 (ru) 2007-08-27
DE60211916T2 (de) 2007-01-04
EP1416918B1 (en) 2006-05-31
EP1416918A1 (en) 2004-05-12
DE60211916D1 (de) 2006-07-06
CN1556695A (zh) 2004-12-22
US20030031708A1 (en) 2003-02-13
CA2454449C (en) 2010-10-26
MXPA04000666A (es) 2004-04-05
JP2005501049A (ja) 2005-01-13
RU2004105268A (ru) 2005-03-10
ATE327738T1 (de) 2006-06-15

Similar Documents

Publication Publication Date Title
WO2007002597A3 (en) Modified-release formulations of a bupropion salt
AU2003274681A1 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
GEP20074047B (en) Pramipexole once-daily dosage form
AP2002002558A0 (en) Pharmaceutical compositions containing polymer and drug assemblies.
AU2003274071A1 (en) Dosage form that is safeguarded from abuse
MX2008012731A (es) Tabletas de paracetamol de liberacion rapida.
MXPA02005562A (es) Superdesintegrante farmaceutico.
MXPA03008420A (es) Forma farmaceutica solida oralmente dispersa.
WO2002011694A3 (en) COMPOSITIONS AND DOSAGE FORMS FOR APPLICATION IN ORAL CAVITY IN THE TREATMENT OF MYCOSIS
TW200618802A (en) Pharmaceutical composition in the form of a gastric retention tablet containing an active ingredient
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
BR0211439A (pt) Composição de carga sinergìstica e comprimido farmacêutico
IL166596A0 (en) Salt of morphine-6-glucoronide
WO2007016350A3 (en) Modified release tablet formulations with enhanced mechanical properties
MXPA05008403A (es) Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.
DE60111503D1 (de) Pharmazeutische zusammensetzungen enthaltend terbinafin
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
PL378106A1 (pl) Sposób wytwarzania zawierającej fibrat kompozycji farmaceutycznej w postaci tabletek oraz tabletki otrzymane tym sposobem
GB2448430A (en) Synergistic binder composition, method for making same and tablets of an active and said binder having advantageous hardness and friability
PL1499278T3 (pl) Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon
EE200400069A (et) Tsitalopraami kasutamine ravimkoostiste valmistamiseks kõrgenenud vererõhu raviks
UA83094C2 (en) Tablet of citalopram hydrobromide
MXPA04006675A (es) Composicion farmaceutica que comprende glitazona y acido 4-oxobutanoico y uso de la misma para tratamiento de diabetes.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 9/14 (2006.01), A61K 9/16 (2006.01), A61K 9/2

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/05/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B25D Requested change of name of applicant approved
B25G Requested change of headquarter approved
B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Free format text: ANULADA A PUBLICACAO CODIGO 25.7 NA RPI NO 2649 DE 13/10/2021 POR TER SIDO INDEVIDA.

B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Free format text: ANULADA A PUBLICACAO CODIGO 25.4 NA RPI NO 2648 DE 05/10/2021 POR TER SIDO INDEVIDA.

B25D Requested change of name of applicant approved
B25G Requested change of headquarter approved
B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 10/05/2022